Citation Formats
Efficacy and Safety of Trastuzumab Emtansine in Her2 Positive Metastatic Breast Cancer: Real-World Experience
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

A. Bahçeci Et Al. , "Efficacy and Safety of Trastuzumab Emtansine in Her2 Positive Metastatic Breast Cancer: Real-World Experience," CANCER INVESTIGATION , vol.39, no.6-7, pp.473-481, 2021

Bahçeci, A. Et Al. 2021. Efficacy and Safety of Trastuzumab Emtansine in Her2 Positive Metastatic Breast Cancer: Real-World Experience. CANCER INVESTIGATION , vol.39, no.6-7 , 473-481.

Bahçeci, A., Paydaş, S., Ak, N., Ferhatoğlu, F., Saip, P. M., Seydaoğlu, G., ... Bilici, M.(2021). Efficacy and Safety of Trastuzumab Emtansine in Her2 Positive Metastatic Breast Cancer: Real-World Experience. CANCER INVESTIGATION , vol.39, no.6-7, 473-481.

Bahçeci, Aykut Et Al. "Efficacy and Safety of Trastuzumab Emtansine in Her2 Positive Metastatic Breast Cancer: Real-World Experience," CANCER INVESTIGATION , vol.39, no.6-7, 473-481, 2021

Bahçeci, Aykut Et Al. "Efficacy and Safety of Trastuzumab Emtansine in Her2 Positive Metastatic Breast Cancer: Real-World Experience." CANCER INVESTIGATION , vol.39, no.6-7, pp.473-481, 2021

Bahçeci, A. Et Al. (2021) . "Efficacy and Safety of Trastuzumab Emtansine in Her2 Positive Metastatic Breast Cancer: Real-World Experience." CANCER INVESTIGATION , vol.39, no.6-7, pp.473-481.

@article{article, author={Aykut Bahçeci Et Al. }, title={Efficacy and Safety of Trastuzumab Emtansine in Her2 Positive Metastatic Breast Cancer: Real-World Experience}, journal={CANCER INVESTIGATION}, year=2021, pages={473-481} }